Pure Extracts Technologies Corp.

As of March 31, 2023, Pure Extracts Technologies Corp. has 116.77M shares outstanding.

These figures are as of March 31, 2023. The price-to-sales ratio is 0.48, and the price-to-book ratio stands at -5.00.

These figures are as of March 31, 2023. The EV/Sales ratio of 1.32 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of March 31, 2023, Pure Extracts Technologies Corp. maintains a current ratio of 0.37, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -908.86, indicating conservative leverage, while an interest coverage ratio of -9.11 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2023, Pure Extracts Technologies Corp. posted a negative return on equity (ROE) of -453.13, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -67.85, reflecting losses generated across the asset base. Inventory turnover of 1.55 indicates how many times Pure Extracts Technologies Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2023, Pure Extracts Technologies Corp. posted a gross margin of 19.93, reflecting its pricing power and cost economics. The operating margin of -150.02 and net profit margin of -163.85 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2023. Free cash flow yield is negative at -66.41: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -59.51, meaning Pure Extracts Technologies Corp. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Pure Extracts Technologies Corp.'s most recent stock split took place on November 5, 2020 with a 6:1 split ratio.

As of March 31, 2023, Pure Extracts Technologies Corp. has an Altman Z-Score of -10.99, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.